1546
A. A. Abbas / Tetrahedron 60 (2004) 1541–1548
colorless crystals (45%), mp 240–42 8C; IR (cm21) 3197
(OH), 1595 (CvN); MS: m/z 703 (Mþþ1, 50%); 1H NMR
(DMSO) d 1.9 (br s, 4H, SCH2CH2), 3.23 (m, 4H, SCH2),
4.15–4.54 (m, 5H, OCH2, CH–OH), 5.53 (d, 1H, J¼3.6 Hz,
OH), 7.11–8.03 (m, 18H, ArH’s), 9.40 (s, 2H,
CHvN) ppm. (Calcd for C37H34N8O3S2 (702.86): C,
63.23; H, 4.88; N, 15.94; S, 9.12. Found: C, 62.99; H,
4.77; N, 16.01; S, 9.31).
159.30 (CH’s) ppm. (Calcd for C38H33N8O4S2Cl (765.31):
C, 56.64; H, 4.35; N, 14.64; S, 8.38, Cl, 4.63. Found: C,
59.88; H, 4.44; N, 14.80; S, 8.20; Cl, 4.50).
3.4.2. 13-Chloroacetoxy-3,23-dibenzyl-12,13,27,28,
29,30-hexahydro-14H-bis[1,2,4]triazolo[4,3-f:3,4-m]-
dibenzo[b,r][1,20,5,6,15,16,8,13]dioxatetraazadithia-
cyclotricosine (11b). With the use of the general procedure
7d gave 11b (70%), mp 170–72 8C; IR (cm21) 1766 (CO),
1600 (CvN); 1H NMR (CDCl3) d 1.93 (br s, 4H,
SCH2CH2), 3.27 (br s, 4H, SCH2), 3.96 (s, 2H, CH2Cl),
4.25 (s, 4H, CH2Ph), 4.36 (d, 4H, J¼5.6 Hz, OCH2), 5.79
(quintet, 1H, J¼5.4 Hz, CH–OCO), 6.93–7.99 (m, 18H,
ArH’s), 9.16 (s, 2H, CHvN) ppm. (Calcd for C41H39N8-
O4S2Cl (807.40): C, 60.99; H, 4.87; N, 13.88; S, 7.94, Cl,
4.39. Found: C, 60.70; H, 4.74; N, 13.95; S, 8.10; Cl, 4.52).
3.3.3. 3,23-Dibenzyl-13-hydroxy-12,13,27,28-tetrahydro-
14H,29H-bis[1,2,4]triazolo[4,3-f:3,4-m]dibenzo[b,r]-
[1,19,5,6,14,15,8,12]dioxatetraazadithiacyclodocosine
(7c). (a) With the use of the general procedure (B) 9 and 2c
gave crude 7c which was crystallized from ethanol as
colorless crystals (40%), mp 182–84 8C; IR (cm21) 3197
1
(OH), 1596 (CvN); MS: m/z 716 (Mþ, 53%); H NMR
(DMSO) d 2.23 (quintet, 2H, J¼5.6 Hz, SCH2CH2), 3.28 (t,
4H, J¼6.6 Hz, SCH2), 4.1–4.35 (m, 5H, OCH2, CH–OH),
4.22 (s, 4H, CH2Ph), 5.5 (d, 1H, J¼4.4 Hz, OH), 7.10–7.97
(m, 18H, ArH’s), 9.28 (s, 2H, CHvN) ppm. (Calcd for
C38H36N8O3S2 (716.89): C, 63.67; H, 5.06; N, 15.63; S,
8.95. Found: C, 62.92; H, 5.22; N, 15.80; S, 9.21).
3.5. Reaction of esters 11a,b with secondary amines
(synthesis of compounds 12a,b, 13 and 14a,b)
General procedure. A mixture of each of 11a,b (5 mmol)
and excess of the appropriate secondary amines (N,N-
diethylamine, morpholine, piperidine and piperazine)
[6 mmol for compounds 13a,b, 14 and 2.5 mmol of
piperazine for compounds 11a,b] in acetone (30 ml) was
heated under reflux for 2 h. The solvent was then removed in
vacuo. The solid obtained was crystallized from the proper
solvent to give compounds 12a,b, 13 and 14a,b,
respectively.
(b) With the use of the general procedure (A) 4a gave 2% of
7c
3.3.4. 3,23-Dibenzyl-13-hydroxy-12,13,27,28,29,30-hexa-
hydro-14H-bis[1,2,4]triazolo[4,3-f:3,4-m]dibenzo[b,r]-
[1,20,5,6,15,16,8,13]dioxatetraazadithiacyclotricosine
(7d). (a) With the use of the general procedure (B) 9 and 2d
gave crude 7d which was crystallized from dioxan as
colorless crystals (50%), mp 170–72 8C; IR (cm21) 3199
3.5.1. 3,23-Diphenyl-13-[2-(N-piperidino)acetoxy]-
12,13,27,28-tetrahydro-14H,29H-bis[1,2,4]triazolo[4,3-
f:3,4-m]dibenzo[b,q][1,19,5,6,14,15,8,12]dioxatetra-
azadithiacyclodocosine (12a). With the use of the general
procedure 11a and morpholine gave crude 12b which was
crystallized from ethanol as colorless crystals (70%), mp
216–18 8C; 1H NMR (CDCl3) d 1.32 (quintet, 2H,
J¼4.6 Hz, N–CH2CH2CH2), 1.49 (quintet, 4H, J¼4.8 Hz,
N–CH2CH2CH2), 2.4 (m, 6H, SCH2CH2, N–CH2CH2-
CH2), 3.17 (s, 2H, CH2CO), 3.48 (br s, 4H, SCH2), 4.41 (d,
4H, J¼5.4 Hz, OCH2), 5.68 (quintet, 1H, J¼5.2 Hz, CH–
OCO), 7.02–8.08 (m, 18H, ArH’s), 9.16 (s, 2H,
CHvN) ppm. (Calcd for C43H43N9O4S2 (814.00): C,
63.45; H, 5.32; N, 15.49; S, 7.88. Found: C, 63.30; H,
5.50; N, 15.52; S, 7.80).
1
(OH), 1599 (CvN); MS: m/z 730 (Mþ, 62%); H NMR
(DMSO) d 1.8 (br s, 4H, SCH2CH2), 3.15 (m, 4H, SCH2),
4.19 (s, 4H, CH2Ph), 4.05–4.32 (m, 5H, OCH2, CH–OH),
5.51 (d, 1H, J¼4 Hz, OH), 7.10–7.99 (m, 18H, ArH’s), 9.29
(s, 2H, CHvN) ppm. (Calcd for C39H38N8O3S2 (730.91):
C, 64.09; H, 5.24; N, 15.33; S, 8.77. Found: C, 63.99; H,
4.97; N, 15.11; S, 8.59).
(b) With the use of the general procedure (A) 4b 2% of 7d
3.4. Synthesis of chloroacetoxy macrocycles 11a,b
General procedure. A solution of each of macrocycles 7a,d
(5 mmol) in DMF (10 ml) was added 2-chloroacetyl
chloride (5 mmol). The reaction mixture was stirred at
room temperature for 3 h. then poured on cursed ice. The
solid obtained was collected by filtration and crystallized
from benzene to afforded colorless crystals of 11a,b.
3.5.2. 3,23-Dibenzyl-13-[2-(N-morpholino)acetoxy]-
12,13,27,28,29,30-hexahydro-14H-bis[1,2,4]triazolo[4,3-
f:3,4-m]dibenzo[b,r][1,20,5,6,15,16,8,13]dioxatetra-
azadithiacyclotricosine (12b). (a) With the use of the
general procedure 11b and morpholine gave crude 12b
which was crystallized from benzene as colorless crystals
(65%), mp 204–6 8C; IR (cm21) 1749 (CO), 1599 (CvN),
1H NMR (CDCl3) d 1.89 (br s, 4H, SCH2CH2), 2.43 (t, 4H,
J¼4.4 Hz, N–CH2CH2–O), 3.17 (s, 2H, CH2CO), 3.23 (br
s, 4H, SCH2), 3.58 (t, 4H, J¼4.4 Hz, N–CH2CH2–O), 4.25
(s, 4H, CH2Ph), 4.35 (d, 4H, J¼4.8 Hz, OCH2), 5.73
(quintet, 1H, J¼5 Hz, CH–OCO), 6.94–8.03 (m, 18H,
ArH’s), 9.18 (s, 2H, CHvN) ppm; 13C (CDCl3) d 27.72,
31.58, 33.21, 52.88, 59.15, 66.58, 66.93, 120.82, 135.83,
144.82, 154.02, 157.62, 168.99 (CH2‘s and C’s); 70.16,
112.04, 121.96, 126.65, 127.02, 128.37, 128.79, 134.10,
156.35 (CH’s) ppm. (Calcd for C45H47N9O5S2 (858.06): C,
3.4.1. 13-Chloroacetoxy-3,23-diphenyl-12,13,27,28-
tetrahydro-14H,29H-bis[1,2,4]triazolo[4,3-f:3,4-m]-
dibenzo[b,q][1,19,5,6,14,15,8,12]dioxatetraazadithia-
cyclodocosine (11a). With the use of the general procedure
7a gave 11a (65%), mp 182–84 8C; IR (cm21) 1749 (CO),
1599 (CvN); 1H NMR (CDCl3) d 2.43 (m, 2H, SCH2CH2),
3.48 (m, 4H, SCH2), 4.02 (s, 2H, CH2Cl), 4.42 (d, 4H,
J¼5 Hz, OCH2), 5.74 (quintet, 1H, J¼5.4 Hz, CH–OCO),
7.0–8.06 (m, 18H, ArH’s), 9.15 (s, 2H, CHvN) ppm; 13C
(CDCl3) d 27.18, 32.77, 40.50, 66.90, 120.90, 126.65,
145.71, 152.80, 157.87, 166.44 (CH2’s and C’s); 72.36,
112.61, 122.28, 127.62, 128.29, 128.45, 129.75, 134.38,